Roxas, Siegreed Rey D.
HRN: 26-44-64 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2025
CEFOTAXIME 500MG (VIAL)
01/02/2025
01/09/2025
IV
170
Q12
PSNB
Waiting Final Action
01/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/02/2025
01/09/2025
IV
51mg
Q24
PSNB
Waiting Final Action